Advertisement
Original Research Obstetrics| Volume 227, ISSUE 2, P273.e1-273.e18, August 2022

Second trimester short cervix is associated with decreased abundance of cervicovaginal lipid metabolites

  • Kristin D. Gerson
    Correspondence
    Corresponding author: Kristin D. Gerson, MD, PhD.
    Affiliations
    Center for Research on Reproduction and Women’s Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

    Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    Search for articles by this author
  • Nancy Yang
    Affiliations
    Center for Research on Reproduction and Women’s Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    Search for articles by this author
  • Lauren Anton
    Affiliations
    Center for Research on Reproduction and Women’s Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    Search for articles by this author
  • Maayan Levy
    Affiliations
    Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    Search for articles by this author
  • Jacques Ravel
    Affiliations
    Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD
    Search for articles by this author
  • Michal A. Elovitz
    Affiliations
    Center for Research on Reproduction and Women’s Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

    Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    Search for articles by this author
  • Heather H. Burris
    Affiliations
    Center for Research on Reproduction and Women’s Health, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

    Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    Search for articles by this author
Published:April 22, 2022DOI:https://doi.org/10.1016/j.ajog.2022.04.031

      Background

      A short cervix is a risk factor for preterm birth. The molecular drivers of a short cervix remain elusive. Metabolites may function as mediators of pathologic processes.

      Objective

      We sought to determine if a distinct cervicovaginal metabolomic profile is associated with a short cervix (<25 mm) to unveil the potential mechanisms by which premature cervical remodeling leads to a short cervix.

      Study Design

      This was a secondary analysis of a completed prospective pregnancy cohort. Cervicovaginal fluid was obtained between 20 and 24 weeks’ gestation. The participants selected for metabolomic profiling were frequency-matched by birth outcome and cervicovaginal microbiota profile. This analysis included 222 participants with cervical length measured. A short cervix was defined as one having length <25 mm, as measured by transvaginal ultrasound. Unpaired t-tests were performed with a Bonferroni correction for multiple comparisons.

      Results

      There were 27 participants with a short cervix, and 195 with normal cervical length. Of the 637 metabolites detected, 26 differed between those with a short cervix and those with normal cervical lengths; 22 were decreased, of which 21 belonged to the lipid metabolism pathway (all P<.000079). Diethanolamine, erythritol, progesterone, and mannitol or sorbitol were increased in the cases of short cervix. Among participants with Lactobacillus-deficient microbiota, only diethanolamine and mannitol or sorbitol differed between short cervix (n=17) and normal cervical length (n=75), both increased.

      Conclusion

      A short cervix is associated with decreased cervicovaginal lipid metabolites, particularly sphingolipids. This class of lipids stabilizes cell membranes and protects against environmental exposures. Increased diethanolamine—an immunostimulatory xenobiotic—is associated with a short cervix. These observations begin to identify the potential mechanisms by which modifiable environmental factors may invoke cell damage in the setting of biological vulnerability, thus promoting premature cervical remodeling in spontaneous preterm birth.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gerson K.D.
        • McCarthy C.
        • Elovitz M.A.
        • Ravel J.
        • Sammel M.D.
        • Burris H.H.
        Cervicovaginal microbial communities deficient in Lactobacillus species are associated with second trimester short cervix.
        Am J Obstet Gynecol. 2020; 222: 491.e1-491.e8
        • Elovitz M.A.
        • Gajer P.
        • Riis V.
        • et al.
        Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery.
        Nat Commun. 2019; 10: 1305
        • DiGiulio D.B.
        • Callahan B.J.
        • McMurdie P.J.
        • et al.
        Temporal and spatial variation of the human microbiota during pregnancy.
        Proc Natl Acad Sci U S A. 2015; 112: 11060-11065
        • Stout M.J.
        • Zhou Y.
        • Wylie K.M.
        • Tarr P.I.
        • Macones G.A.
        • Tuuli M.G.
        Early pregnancy vaginal microbiome trends and preterm birth.
        Am J Obstet Gynecol. 2017; 217: 356.e1-356.e18
        • Callahan B.J.
        • DiGiulio D.B.
        • Goltsman D.S.A.
        • et al.
        Replication and refinement of a vaginal microbial signature of preterm birth in two racially distinct cohorts of US women.
        Proc Natl Acad Sci U S A. 2017; 114: 9966-9971
        • Fettweis J.M.
        • Serrano M.G.
        • Brooks J.P.
        • et al.
        The vaginal microbiome and preterm birth.
        Nat Med. 2019; 25: 1012-1021
        • Brown R.G.
        • Chan D.
        • Terzidou V.
        • et al.
        Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage.
        BJOG. 2019; 126: 916-925
        • Brown R.G.
        • Marchesi J.R.
        • Lee Y.S.
        • et al.
        Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin.
        BMC Med. 2018; 16: 9
        • Kindinger L.M.
        • Bennett P.R.
        • Lee Y.S.
        • et al.
        The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk.
        Microbiome. 2017; 5: 6
        • Kindinger L.M.
        • MacIntyre D.A.
        • Lee Y.S.
        • et al.
        Relationship between vaginal microbial dysbiosis, inflammation, and pregnancy outcomes in cervical cerclage.
        Sci Transl Med. 2016; 8 (350ra102)
        • MacIntyre D.A.
        • Chandiramani M.
        • Lee Y.S.
        • et al.
        The vaginal microbiome during pregnancy and the postpartum period in a European population.
        Sci Rep. 2015; 5: 8988
        • Kayama H.
        • Takeda K.
        Manipulation of epithelial integrity and mucosal immunity by host and microbiota-derived metabolites.
        Eur J Immunol. 2020; 50: 921-931
        • Lee-Sarwar K.A.
        • Lasky-Su J.
        • Kelly R.S.
        • Litonjua A.A.
        • Weiss S.T.
        Metabolome–microbiome crosstalk and human disease.
        Metabolites. 2020; 10: 181
        • Barbara G.
        • Barbaro M.R.
        • Fuschi D.
        • et al.
        Inflammatory and microbiota-related regulation of the intestinal epithelial barrier.
        Front Nutr. 2021; 8: 718356
        • Gasaly N.
        • de Vos P.
        • Hermoso M.A.
        Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation.
        Front Immunol. 2021; 12: 658354
        • Nold C.
        • Anton L.
        • Brown A.
        • Elovitz M.
        Inflammation promotes a cytokine response and disrupts the cervical epithelial barrier: a possible mechanism of premature cervical remodeling and preterm birth.
        Am J Obstet Gynecol. 2012; 206: 208.e1-208.e7
        • Anton L.
        • DeVine A.
        • Sierra L.J.
        • Brown A.G.
        • Elovitz M.A.
        MIR-143 and miR-145 disrupt the cervical epithelial barrier through dysregulation of cell adhesion, apoptosis and proliferation.
        Sci Rep. 2017; 7: 3020
        • Anton L.
        • Sierra L.J.
        • DeVine A.
        • et al.
        Common cervicovaginal microbial supernatants alter cervical epithelial function: mechanisms by which Lactobacillus crispatus contributes to cervical health.
        Front Microbiol. 2018; 9: 2181
        • Dude C.M.
        • Saylany A.
        • Brown A.
        • Elovitz M.
        • Anton L.
        Microbial supernatants from Mobiluncus mulieris, a bacteria strongly associated with spontaneous preterm birth, disrupts the cervical epithelial barrier through inflammatory and miRNA mediated mechanisms.
        Anaerobe. 2020; 61: 102127
        • Ghartey J.
        • Bastek J.A.
        • Brown A.G.
        • Anglim L.
        • Elovitz M.A.
        Women with preterm birth have a distinct cervicovaginal metabolome.
        Am J Obstet Gynecol. 2015; 212: 776.e1-776.e12
        • Ghartey J.
        • Anglim L.
        • Romero J.
        • Brown A.
        • Elovitz M.A.
        Women with symptomatic preterm birth have a distinct cervicovaginal metabolome.
        Am J Perinatol. 2017; 34: 1078-1083
        • Oliver A.
        • LaMere B.
        • Weihe C.
        • et al.
        Cervicovaginal microbiome composition is associated with metabolic profiles in healthy pregnancy.
        mBio. 2020; 11 (e01851–20)
        • Ansari A.
        • Lee H.
        • You Y.A.
        • et al.
        Identification of potential biomarkers in the cervicovaginal fluid by metabolic profiling for preterm birth.
        Metabolites. 2020; 10: 349
        • Flaviani F.
        • Hezelgrave N.L.
        • Kanno T.
        • et al.
        Cervicovaginal microbiota and metabolome predict preterm birth risk in an ethnically diverse cohort.
        JCI Insight. 2021; 6e149257
        • Marangoni A.
        • Laghi L.
        • Zagonari S.
        • et al.
        New insights into vaginal environment During pregnancy.
        Front Mol Biosci. 2021; 8: 656844
        • Polat I.H.
        • Marin S.
        • Rios J.
        • et al.
        Exploratory and confirmatory analysis to investigate the presence of vaginal metabolome expression of microbial invasion of the amniotic cavity in women with preterm labor using high-performance liquid chromatography.
        Am J ObstetGynecol. 2021; 224: 90.e1-90.e9
        • Pruski P.
        • Correia G.D.S.
        • Lewis H.V.
        • et al.
        Direct on-swab metabolic profiling of vaginal microbiome host interactions during pregnancy and preterm birth.
        Nat Commun. 2021; 12: 5967
        • Gerson K.D.
        • Liao J.
        • McCarthy C.
        • et al.
        A non-optimal cervicovaginal microbiota in pregnancy is associated with a distinct metabolomic signature among non-Hispanic Black individuals.
        Sci Rep. 2021; 11: 22794
        • Ravel J.
        • Gajer P.
        • Abdo Z.
        • et al.
        Vaginal microbiome of reproductive-age women.
        Proc Natl Acad Sci U S A. 2011; 108: 4680-4687
        • Evans A.M.
        • DeHaven C.D.
        • Barrett T.
        • Mitchell M.
        • Milgram E.
        Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems.
        Anal Chem. 2009; 81: 6656-6667
        • Evans A.M.
        • Bridgewater B.R.
        • Liu Q.
        • et al.
        High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high- throughput profiling metabolomics.
        Metabolomics. 2014; 4
        • Ford L.
        • Kennedy A.D.
        • Goodman K.D.
        • et al.
        Precision of a clinical metabolomics profiling platform for use in the identification of inborn errors of metabolism.
        J Appl Lab Med. 2020; 5: 342-356
        • Dehaven C.D.
        • Evans A.M.
        • Dai H.
        • Lawton K.A.
        Organization of GC/MS and LC/MS metabolomics data into chemical libraries.
        J Cheminform. 2010; 2: 9
        • Haug K.
        • Cochrane K.
        • Nainala V.C.
        • et al.
        MetaboLights: a resource evolving in response to the needs of its scientific community.
        Nucleic Acids Res. 2020; 48: D440-D444
        • Hornung R.W.
        • Reed L.D.
        Estimation of average concentration in the presence of nondetectable values.
        Appl Occup Environ Hyg. 1990; 5: 46-51
      1. Team RC. R: a language and environment Fr statistical computing Vienna, Austria. 2021, Philadelphia, PA. Available at: https://www.R-project.org/. Accessed October 1, 2021.

        • Hannun Y.A.
        • Obeid L.M.
        Sphingolipids and their metabolism in physiology and disease.
        Nat Rev Mol Cell Biol. 2018; 19: 175-191
        • Eich C.
        • Manzo C.
        • de Keijzer S.
        • et al.
        Changes in membrane sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters.
        Sci Rep. 2016; 6: 20693
        • Holleran W.M.
        • Takagi Y.
        • Uchida Y.
        Epidermal sphingolipids: metabolism, function, and roles in skin disorders.
        FEBS Lett. 2006; 580: 5456-5466
        • Lipsky Z.W.
        • Marques C.N.H.
        • German G.K.
        Lipid depletion enables permeation of Staphylococcus aureus bacteria through human stratum corneum.
        Tissue Barriers. 2020; 81754706
        • Sanches J.M.
        • Giraldo P.C.
        • Amaral R.
        • et al.
        Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: a non-targeted LC-MS pilot study.
        PLoS One. 2018; 13e0202401
        • Srinivasan S.
        • Morgan M.T.
        • Fiedler T.L.
        • et al.
        Metabolic signatures of bacterial vaginosis.
        mBio. 2015; 6: e00204-e00215
        • MacNeill C.
        • de Guzman G.S.
        • Lupo K.
        • Umstead T.
        • Phelps D.S.
        • Floros J.
        Anti- inflammatory effect of surfactant lipid in the vaginal mucosa: a pilot study.
        J Low Genit Tract Dis. 2019; 23: 71-74
        • Ilhan Z.E.
        • Łaniewski P.
        • Thomas N.
        • Roe D.J.
        • Chase D.M.
        • Herbst-Kralovetz M.M.
        Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.
        EBiomedicine. 2019; 44: 675-690
        • National Toxicology Program
        NTP toxicology and carcinogenesis studies of diethanolamine (CAS No. 111-42–2) in F344/N rats and B6C3F1 mice (dermal studies).
        Natl Toxicol Program Tech Rep Ser. 1999; 478: 1-212
        • National Toxicology Program
        NTP toxicology and carcinogenesis studies of lauric acid diethanolamine condensate (CAS NO. 120-40–1) in F344/N rats and B6C3F1 mice (dermal studies).
        Natl Toxicol Program Tech Rep Ser. 1999; 480: 1-200
        • Mathews J.M.
        • deCosta K.
        • Thomas B.F.
        Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration.
        Drug Metab Dispos. 1996; 24: 702-710
        • Craciunescu C.N.
        • Niculescu M.D.
        • Guo Z.
        • Johnson A.R.
        • Fischer L.
        • Zeisel S.H.
        Dose response effects of dermally applied diethanolamine on neurogenesis in fetal mouse hippocampus and potential exposure of humans.
        Toxicol Sci. 2009; 107: 220-226
        • Vanuytsel T.
        • Tack J.
        • Farre R.
        The role of intestinal permeability in gastrointestinal disorders and current methods of evaluation.
        Front Nutr. 2021; 8: 717925
        • Timmons B.
        • Akins M.
        • Mahendroo M.
        Cervical remodeling during pregnancy and parturition.
        Trends Endocrinol Metab. 2010; 21: 353-361
        • Mahendroo M.
        Cervical remodeling in term and preterm birth: insights from an animal model.
        Reproduction. 2012; 143: 429-438
        • Yellon S.M.
        Immunobiology of cervix ripening.
        Front Immunol. 2019; 10: 3156
        • Lucki N.C.
        • Sewer M.B.
        The interplay between bioactive sphingolipids and steroid hormones.
        Steroids. 2010; 75: 390-399